Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2020.10.14.339150: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementConsent: The subjects provided signed written informed consent.
    IRB: All procedures and methods were approved by the Institutional Review Board for Human Use at the University of Alabama at Birmingham, and all experiments were performed in accordance with relevant guidelines and regulations.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variableIn a prophylactic experiment, 6-week old, female hamsters were IP injection of 10 mg/kg of hmAb 1212C2 (n=6), 1206D1 (n=3), human IgG1 Isotype control mAb (BioXcell, Labanon, NH; n=6), or PBS (n=5).
    Cell Line Authenticationnot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    At 24 hpi, infected cells were fixed with 10% neutral formalin for 24 h and were immune-stained using anti-NP monoclonal 1C7C7 antibody (21).
    anti-NP
    suggested: None
    Experimental Models: Cell Lines
    SentencesResources
    Paired heavy and light chain genes cloned into IgG1 expression vectors and were transfected into HEK293T cells and culture supernatant was concentrated using 100,000 MWCO Amicon Ultra centrifugal filters (Millipore-Sigma, Cork, Ireland), and IgG captured and eluted from Magne Protein A beads (Promega, Madison, WI) as previously described (27, 39).
    HEK293T
    suggested: None
    Nucleocapsid (Sino Biological), and HepG2 whole cell lysate (Abcam, Cambridge, MA)
    HepG2
    suggested: CLS Cat# 300198/p2277_Hep-G2, RRID:CVCL_0027)
    Briefly, confluent monolayers of Vero E6 cells were mock infected or infected with the indicated SARS-CoV-2.
    Vero E6
    suggested: RRID:CVCL_XD71)
    VeroE6/TMPRSS2 cells were seeded at 2 x 104 cells/well in opaque plates (Greiner 655083).
    VeroE6/TMPRSS2
    suggested: JCRB Cat# JCRB1819, RRID:CVCL_YQ49)
    Software and Algorithms
    SentencesResources
    Cryopreserved cells were thawed and stained for flow cytometry similar as previously described (39), using anti-CD 19-APC-Cy7 (SJ25C1, BD Biosciences), HIV gp140-AlexaFluor647, SARS-CoV-2 RBD-BV421, CD3-BV510 (OKT3, Biolegend), CD4-BV510 (HI30, Biolegend), IgD-FITC (IA6-2, BD Biosciences), CD27-PE (CLB-27/1, Life Technologies), Annexin V-PerCP-Cy5.5 (Biolegend), and Live/Dead aqua (Molecular
    BD Biosciences
    suggested: (BD Biosciences, RRID:SCR_013311)
    Immunoglobulin sequences were analyzed by IgBlast (www.ncbi.nlm.nih.gov/igblast) and IMGT/V-QUEST (http://www.imgt.org/IMGT_vquest/vquest) to determine which sequences should lead to productive immunoglobulin, to identify the germline V(D)J gene segments with the highest identity, and to scrutinize sequence properties.
    IgBlast
    suggested: (IgBLAST, RRID:SCR_002873)
    A non-linear regression curve fit analysis over the dilution curve can be performed using GraphPad Prism to calculate NT50.
    GraphPad Prism
    suggested: (GraphPad Prism, RRID:SCR_002798)
    For each day, lungs and nasal turbinate were collected removed and photographed on white paper towels to look for gross pathology using a macroscopic pathology scoring analysis measure the distributions of pathological lesions, including consolidation, congestion, and pneumonic lesions using ImageJ software (NIH).
    ImageJ
    suggested: (ImageJ, RRID:SCR_003070)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).


    Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on page 38. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • No funding statement was detected.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.